SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/01/2016
Entire Document
 

Table of Contents

Illinois. Future milestone payments under the AskBio License and minimum lease payments under the Bannockburn lease as of September 30, 2015 are follows:

Contractual Obligations
 
Total
 
Remainder of
2015
 
1 to 3 Years
 
4 to 5 Years
 
More Than
5 Years
 

Future minimum lease payments

  $ 384,083   $   $ 225,968   $ 158,115   $  

Milestone payments under AskBio License

    9,600,000 (1)                

(1)
Represents aggregate potential clinical development and sales based milestone obligation amounts. The actual amount and timing of these payments are uncertain, as the payments are contingent upon future events.

Off-Balance Sheet Arrangements

          During the periods presented, we did not have, nor do we currently have, any off-balance sheet arrangements as defined under SEC rules.

Quantitative and Qualitative Disclosure about Market Risk

Interest Rate Sensitivity

          Our primary exposure to market risk for our cash and cash equivalents is interest income sensitivity, which is affected by changes in the general level of U.S interest rates. However, we do not believe a sudden change in the interest rates would have a material impact on our financial condition or results of operations. A hypothetical 10% change in interest rates during any of the periods presented would not have had a material impact on our consolidated financial statements.

103



© AveXis, Inc. All Rights Reserved.